Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2013. The document serves as a notification of a transaction involving a Connected Person under the Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction and does not contain financial performance data.
Material Changes
The filing details the acquisition of 11 Ordinary Shares by Mr P C Thomson and Mrs K Thomson on October 3, 2013. The shares were purchased at a price of 1569.68 pence per share through the reinvestment of dividends under the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Points
- Verify the share price of 1569.68 pence per Ordinary Share on October 3, 2013.
- Confirm the total number of shares acquired (11) by the Connected Persons.
- Review the terms of the GlaxoSmithKline ShareReward Plan regarding dividend reinvestment.